Evidence map›Paper›PMID 33317147›Full record

ArticleInternational journal of environmental research and public health2020

Management of Occupational Risk Prevention of Nanomaterials Manufactured in Construction Sites in the EU.

Mónica López-Alonso, Beatriz Díaz-Soler, María Martínez-Rojas, Carlos Fito-López, María Dolores Martínez-Aires

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mónica López-AlonsoDepartment of Construction Engineering and Projects, University of Granada, 18010 Granada, Spain.
Beatriz Díaz-SolerDepartment of Building Construction, University of Granada, 18010 Granada, Spain.
María Martínez-RojasDepartment of Business Administration and Economics, University of Málaga, 29016 Málaga, Spain.
Carlos Fito-LópezITENE, Technological Institute of Packaging, Transport and Logistics, 46980 Paterna, Spain.ORCID 0000-0001-5437-5519
María Dolores Martínez-AiresDepartment of Building Construction, University of Granada, 18010 Granada, Spain.ORCID 0000-0002-9292-5048

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, nanotechnology plays a key role for technological innovation, including the construction sector. An exponential increase is expected in its application, although this has been hampered by the current degree of uncertainty regarding the potential effects of nanomaterials on both human health and the environment. The accidents, illnesses, and disease related to the use of nanoproducts in the construction sector are difficult to identify. For this purpose, this work analyzes in depth the products included in recognized inventories and the safety data sheets of these construction products. Based on this analysis, a review of the recommendations on the use of manufactured nanomaterials at construction sites is performed. Finally, a protocol is proposed with the aim of it serving as a tool for technicians in decision-making management at construction sites related to the use of manufactured nanomaterials. This proposed protocol should be an adaptive and flexible tool while the manufactured nanomaterials-based work continues to be considered as an "emerging risk," despite the expectation that the protocol will be useful for the development of new laws and recommendations for occupational risk prevention management.

Indexed as

Construction IndustryNanostructuresOccupational HealthRisk ManagementDecision MakingEnvironmentEuropean UnionHumansNanotechnologyWorkplaceconstruction siteengineered nanomaterialsnanosafetyoccupational risk prevention managementsafety protocol

Identifiers

PMID33317147
PMCPMC7763745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.